Burrill & Company Forms Joint Bio Investment Fund With Korea - Bio Korea 2009

SEOUL - Korean pharmaceutical outfits and investors should focus more on burgeoning biotech companies and take advantage of the Korean government's increasing interest in funding the industry, Burrill & Company CEO Steven Burrill said at the Bio Korea 2009 meeting in Seoul Sept. 16